Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.44 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.44 |
| ▸ | GJA1 | P17302 | 1/20 | 0.43 |
| ▸ | GJB2 | P29033 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CDK1 | P06493 | 1/20 | 0.43 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 3/20 | 0.41 |
| ▸ | IGF2R | P11717 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactulose SCHEMBL18470690 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL18912 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL15942980 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL11892653 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL12787176 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL18479188 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL11890264 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL15942982 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL17241809 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL17623952 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116635712-A | Programmable nanoreactor for random sensing (PNRSS) | 南京大学 | 2023-08-22 | — | — | CN | claimed |
| US-20090082307-A1 | METHOD FOR PRODUCING OLIGOPOLYSACCHARIDES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) | 2009-03-26 | — | — | US | claimed |
| EP-1637611-A1 | Method for producing oligosaccharides | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2006-03-22 | — | — | EP | claimed |
| EP-1194584-B1 | METHOD FOR PRODUCING OLIGOPOLYSACCHARIDES | CENTRE NAT RECH SCIENT (FR) | 2006-02-22 | — | — | EP | claimed |
| EP-1194584-A1 | METHOD FOR PRODUCING OLIGOPOLYSACCHARIDES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2002-04-10 | — | — | EP | claimed |
| WO-2001004341-A1 | METHOD FOR PRODUCING OLIGOPOLYSACCHARIDES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2001-01-18 | — | — | WO | claimed |
| JP-2150240-A | — | — | None | — | — | JP | disclosed |
| CN-119391683-A | Cellobiose epimerase mutant and application thereof | 合肥工业大学 | 2025-02-07 | — | — | CN | disclosed |
| CN-116635712-A | Programmable nanoreactor for random sensing (PNRSS) | 南京大学 | 2023-08-22 | — | — | CN | disclosed |
| US-20210252031-A1 | USE OF LACTULOSE IN THE TREATMENT OF AUTISM | CUREMARK, LLC | 2021-08-19 | — | — | US | disclosed |
| US-11033563-B2 | Use of lactulose in the treatment of autism | CUREMARK, LLC (US) | 2021-06-15 | — | — | US | disclosed |
| US-20200296980-A1 | METHOD OF GENERATING A SACCHARIDE CONTAINING A GALACTOSE AND A FRUCTOSE MOIETY EMPLOYING ENZYME WITH TRANSGALACTOSYLATING ACTIVITY | DUPONT NUTRITION BIOSCI APS (DK) | 2020-09-24 | — | — | US | disclosed |
| US-20200087690-A1 | A METHOD OF INHIBITING ISOMERIZATION OF A REDUCING SACCHARIDE UPON THERMAL TREATMENT | CHR. HANSEN A/S (DK) | 2020-03-19 | — | — | US | disclosed |
| EP-0475160-B1 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 1996-02-14 | — | — | EP | disclosed |
| EP-0622374-A1 | Process for the preparation of crystalline lactulose from commercial syrups | INALCO S.p.A. (IT) | 1994-11-02 | — | — | EP | disclosed |
| US-5304251-A | Storage stable, solvent-free purity | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 1994-04-19 | — | — | US | disclosed |
| EP-0318630-B1 | Method for preparing high purity cristalline lactulose and the product obtained | INALCO SPA (IT) | 1993-12-29 | — | — | EP | disclosed |
| EP-0475160-A1 | Preparation for drug application in minute droplet form | Cevc, Gregor, Prof. Dr. (DE) | 1992-03-18 | — | — | EP | disclosed |
| US-5003061-A | Crystallization of lactulose from a solution of lactulose by seeding | SIRAC SRL (IT) | 1991-03-26 | — | — | US | disclosed |
| JP-H02150240-A | CHEWING GUM | KUDO TSUTOMU | 1990-06-08 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11033563-B2 | Use of lactulose in the treatment of autism | SI, ALB, AADAT | MEN1 2830/4885KMT2A 1854/4885LGALS8 333/4885 |
| US-20210252031-A1 | USE OF LACTULOSE IN THE TREATMENT OF AUTISM | SI, ALB, AADAT | MEN1 2830/4885KMT2A 1854/4885LGALS8 333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.